Recruited macrophages elicit atrial fibrillation

Maarten Hulsmans1,2, Maximilian J Schloss1,2, I-Hsiu Lee1,2

  • 1Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Science (New York, N.Y.)
|July 13, 2023
PubMed
Summary

Immune cells, specifically SPP1+ macrophages, drive atrial fibrillation by disrupting heart contractions. Targeting these macrophages offers a new therapeutic strategy for preventing stroke and heart failure.